Malathi Kullappan

595 total citations
25 papers, 392 citations indexed

About

Malathi Kullappan is a scholar working on Molecular Biology, Infectious Diseases and Computational Theory and Mathematics. According to data from OpenAlex, Malathi Kullappan has authored 25 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Infectious Diseases and 7 papers in Computational Theory and Mathematics. Recurrent topics in Malathi Kullappan's work include Computational Drug Discovery Methods (7 papers), Antibiotic Resistance in Bacteria (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Malathi Kullappan is often cited by papers focused on Computational Drug Discovery Methods (7 papers), Antibiotic Resistance in Bacteria (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Malathi Kullappan collaborates with scholars based in India, Sweden and Saudi Arabia. Malathi Kullappan's co-authors include Sudha Ramaiah, Anand Anbarasu, Krishna Mohan Surapaneni, Vishnu Priya Veeraraghavan, Harpreet Singh, Vivek Anand Manivel, Devadasan Velmurugan, Shilpa Bhandi, G. Baskar and A. Kistan and has published in prestigious journals such as Molecules, BioMed Research International and Journal of Cellular Biochemistry.

In The Last Decade

Malathi Kullappan

25 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Malathi Kullappan India	12	159	106	71	56	50	25	392
Elijah Kolawole Oladipo Nigeria	10	230 1.4×	124 1.2×	104 1.5×	75 1.3×	35 0.7×	67	540
Jacilene Silva Brazil	8	119 0.7×	64 0.6×	98 1.4×	75 1.3×	44 0.9×	23	328
Muhammad Nasir Iqbal Pakistan	11	170 1.1×	113 1.1×	35 0.5×	74 1.3×	40 0.8×	47	475
Jaykant Vora India	12	155 1.0×	93 0.9×	40 0.6×	62 1.1×	43 0.9×	14	407
Dev Bukhsh Singh India	13	215 1.4×	124 1.2×	32 0.5×	54 1.0×	59 1.2×	45	500
Mohamed GabAllah Egypt	10	115 0.7×	78 0.7×	105 1.5×	88 1.6×	41 0.8×	22	402
Priyashi Rao India	14	187 1.2×	147 1.4×	96 1.4×	59 1.1×	59 1.2×	24	422
Mark Tristan J. Quimque Philippines	13	162 1.0×	103 1.0×	61 0.9×	64 1.1×	67 1.3×	26	447
Kiran Bharat Lokhande India	16	289 1.8×	191 1.8×	94 1.3×	111 2.0×	47 0.9×	62	653
Sundaraj Rajamanikandan India	11	170 1.1×	59 0.6×	31 0.4×	44 0.8×	26 0.5×	21	348

Countries citing papers authored by Malathi Kullappan

Since Specialization

Citations

This map shows the geographic impact of Malathi Kullappan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malathi Kullappan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malathi Kullappan more than expected).

Fields of papers citing papers by Malathi Kullappan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malathi Kullappan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malathi Kullappan. The network helps show where Malathi Kullappan may publish in the future.

Co-authorship network of co-authors of Malathi Kullappan

This figure shows the co-authorship network connecting the top 25 collaborators of Malathi Kullappan. A scholar is included among the top collaborators of Malathi Kullappan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malathi Kullappan. Malathi Kullappan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kullappan, Malathi, et al.. (2022). Ellagic Acid as a Potential Inhibitor against the Nonstructural Protein NS3 Helicase of Zika Virus: A Molecular Modelling Study. BioMed Research International. 2022(1). 2044577–2044577. 7 indexed citations

Kullappan, Malathi, Shankargouda Patil, Vishnu Priya Veeraraghavan, et al.. (2022). Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach. Journal of Infection and Public Health. 15(11). 1180–1191. 9 indexed citations

Veeraraghavan, Vishnu Priya, Rosy Vennila, Jeswanth Sathyanesan, et al.. (2022). Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line. Journal of the Egyptian National Cancer Institute. 34(1). 51–51. 5 indexed citations

Veeraraghavan, Vishnu Priya, et al.. (2022). Knowledge, attitudes on falls and awareness of hospitalized patient's fall risk factors among the nurses working in Tertiary Care Hospitals. AIMS Medical Science. 9(2). 304–321. 4 indexed citations

Veeraraghavan, Vishnu Priya, et al.. (2021). Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach. Antibiotics. 10(5). 535–535. 10 indexed citations

Veeraraghavan, Vishnu Priya, et al.. (2021). Knowledge on cervical cancer and perceived barriers to the uptake of HPV vaccination among health professionals. BMC Women s Health. 21(1). 65–65. 16 indexed citations

Baskar, G., et al.. (2021). Machine learning modeling to identify affinity improved biobetter anticancer drug trastuzumab and the insight of molecular recognition of trastuzumab towards its antigen HER2. Journal of Biomolecular Structure and Dynamics. 40(22). 11638–11652. 5 indexed citations

Kullappan, Malathi, et al.. (2021). Understanding the binding conformation of ceftolozane/tazobactam with Metallo‐β‐lactamases VIM‐5 and IMP‐7 of Pseudomonas aeruginosa: A molecular docking and virtual screening process. Journal of Molecular Recognition. 34(9). e2898–e2898. 3 indexed citations

Kullappan, Malathi, et al.. (2021). Physico-Chemical Characterization of Diclofenac and Rasagiline Salts and its Relationship for Development of Sublingual Drug Delivery Systems. International Journal of Pharmaceutical Sciences and Drug Research. 60–66. 3 indexed citations

10.

Kullappan, Malathi, et al.. (2021). Elucidating the role of N440K mutation in SARS-CoV-2 spike – ACE-2 binding affinity and COVID-19 severity by virtual screening, molecular docking and dynamics approach. Journal of Biomolecular Structure and Dynamics. 41(3). 912–929. 15 indexed citations

11.

Veeraraghavan, Vishnu Priya, Malathi Kullappan, Devadasan Velmurugan, et al.. (2021). Molecular modeling studies of the effects of withaferin A and its derivatives against oncoproteins associated with breast cancer stem cell activity. Process Biochemistry. 111. 186–199. 6 indexed citations

12.

Kullappan, Malathi, Sudha Ramaiah, & Anand Anbarasu. (2019). Comparative Molecular Field Analysis and Molecular Docking Studies on Quinolinone Derivatives Indicate Potential Hepatitis C Virus Inhibitors. Cell Biochemistry and Biophysics. 77(2). 139–156. 5 indexed citations

13.

Kullappan, Malathi, Anand Anbarasu, & Sudha Ramaiah. (2019). Identification of potential inhibitors for Klebsiella pneumoniae carbapenemase-3: a molecular docking and dynamics study. Journal of Biomolecular Structure and Dynamics. 37(17). 4601–4613. 25 indexed citations

14.

Kullappan, Malathi, et al.. (2018). FtsA as a cidal target for Staphylococcus aureus: Molecular docking and dynamics studies. Journal of Cellular Biochemistry. 120(5). 7751–7758. 30 indexed citations

15.

Kullappan, Malathi & Sudha Ramaiah. (2018). Mechanism of imipenem resistance in metallo‐β‐lactamases expressing pathogenic bacterial spp. and identification of potential inhibitors: An in silico approach. Journal of Cellular Biochemistry. 120(1). 584–591. 4 indexed citations

16.

Kullappan, Malathi, et al.. (2018). Insights on inhibition of Plasmodium falciparum plasmepsin I by novel epoxyazadiradione derivatives – molecular docking and comparative molecular field analysis. Journal of Biomolecular Structure and Dynamics. 37(12). 3168–3182. 21 indexed citations

17.

Kullappan, Malathi & Sudha Ramaiah. (2018). Bioinformatics approaches for new drug discovery: a review. Biotechnology and Genetic Engineering Reviews. 34(2). 243–260. 44 indexed citations

18.

Kullappan, Malathi & Sudha Ramaiah. (2016). Molecular Docking and Molecular Dynamics Studies to Identify Potential OXA-10 Extended Spectrum β-Lactamase Non-hydrolysing Inhibitors for Pseudomonas aeruginosa. Cell Biochemistry and Biophysics. 74(2). 141–155. 18 indexed citations

19.

Kullappan, Malathi, Anand Anbarasu, & Sudha Ramaiah. (2016). Exploring the resistance mechanism of imipenem in carbapenem hydrolysing class D beta-lactamases OXA-143 and its variant OXA-231 (D224A) expressing Acinetobacter baumannii: An in-silico approach. Computational Biology and Chemistry. 67. 1–8. 18 indexed citations

20.

Kullappan, Malathi, Anand Anbarasu, & Sudha Ramaiah. (2016). Ethyl Iso-allocholate from a Medicinal Rice Karungkavuni Inhibits Dihydropteroate Synthase in Escherichia coli: A Molecular Docking and Dynamics Study. Indian Journal of Pharmaceutical Sciences. 78(6). 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact